Court May Ask Roche To Pay Amgen 22.5 Percent Royalty To Market Mircera

A district court judge issued a preliminary injunction blocking Roche's launch of Mircera (epoetin beta) in the United States and suggested the terms under which Roche might begin selling its anti-anemia drug